ACE inhibitors used in about 30% of CHF cases: Keystone plan encourages ACEs, close patient contact.
Executive Summary
ACE INHIBITOR USE FOR CONGESTIVE HEART FAILURE OCCURS IN ABOUT 30% of appropriate cases in the face of literature references on the treatment benefits. Despite general recognition of the value of angiotensin-converting enzyme inhibitors in congestive heart failure, the products remain underused, Merck-Medco VP-Clinical Education and Training David Angaran told an April 23 session of the Ohio Pharmaceutical Seminar sponsored by Ohio State Pharmacy College in Columbus.